Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology

Diagnosis and Interpreting Your Tests

At a Glance

Autoimmune myocarditis usually cannot be confirmed by one test. Doctors combine troponin and other blood tests, ECG, echocardiography, cardiac MRI, and sometimes a heart biopsy to identify inflammation, assess heart function, and rule out heart attacks or similar conditions.

Diagnosing autoimmune myocarditis is rarely a “one-test” process. Because the symptoms can mimic many other conditions, your doctors use a multimodal approach—a combination of blood work, electrical monitoring, and advanced imaging—to build a complete picture of what is happening in your heart muscle [1][2].

The Initial Screen: Blood and Electrical Tests

The diagnostic journey usually begins with these foundational tools:

  • High-Sensitivity Troponin: This blood test measures a protein released when heart cells are damaged. While a high level confirms the heart is under stress, it doesn’t tell us why. In autoimmune myocarditis, these levels can fluctuate or remain persistently high [3][4].
  • Natriuretic Peptides (BNP/NT-proBNP): Blood tests that check for heart stretch or fluid overload.
  • ECG (Electrocardiogram): This tracks your heart’s electrical activity. While it often shows abnormalities like ST-segment changes or T-wave inversions, these are not unique to myocarditis and can also be seen in traditional heart attacks [5][6].
  • Echocardiogram: An ultrasound of the heart to evaluate its structure and pumping function.

The Imaging: Cardiac MRI (CMR)

The Cardiac MRI is currently the most important non-invasive tool for evaluating suspected myocarditis. To support the diagnosis, radiologists use the 2018 Lake Louise Criteria, which look for evidence from two “domains” [7][8]:

  1. The T2 Domain (Edema): This looks for signs of swelling or fluid buildup in the heart muscle. Tests like T2 mapping or T2-STIR imaging highlight these “wet” areas [7][9].
  2. The T1 Domain (Tissue Injury): This looks for actual damage.
    • Native T1 Mapping: Measures early changes in the heart tissue [10].
    • Late Gadolinium Enhancement (LGE): A contrast dye is used to highlight areas of injury or inflammation. In myocarditis, this LGE usually appears in the “mid-wall” or outer layers of the heart [11][12]. Note that LGE indicates injury or inflammation, and is not synonymous with permanent scar.

While the 2018 Lake Louise criteria support a clinical diagnosis when interpreted alongside other tests, they are not an absolute confirmation and can be negative if disease is early, late, or focal.

Advanced Ultrasound: Global Longitudinal Strain (GLS)

A standard ultrasound (echocardiogram) focuses on the Ejection Fraction (EF)—how much blood the heart pumps. However, autoimmune myocarditis can be “silent” on a standard echo.

Doctors now use Global Longitudinal Strain (GLS) to see how the heart muscle fibers are stretching and deforming [13]. GLS can often detect subtle changes even when the Ejection Fraction looks normal [10][14].

When is a Heart Biopsy Considered?

An Endomyocardial Biopsy (EMB)—taking a tiny sample of heart tissue—is considered selectively when the result is likely to change urgent treatment [15][16].

  • Fulminant Disease: When the heart is failing rapidly and standard treatments aren’t working [16].
  • Specific Subtypes: When doctors suspect Giant-Cell Myocarditis or Eosinophilic Myocarditis, which require very specific, aggressive treatments [17][18].
  • Limitations: Biopsy has procedural risks, and because disease can be patchy, sampling can be falsely negative. Urgent supportive or immunosuppressive treatment should not be delayed solely to obtain a biopsy when the clinical situation is unstable [19].

Ruling Out the “Look-Alikes”

Because the heart has a limited number of ways to signal distress, several other conditions can look exactly like autoimmune myocarditis at first glance, prompting coronary evaluation or infectious testing [11]:

  • MINOCA: A “heart attack” that happens even though the coronary arteries are not blocked [12].
  • Takotsubo Syndrome: Often called “Broken Heart Syndrome,” where the heart muscle temporarily weakens due to intense stress [20][21].
  • Cardiac Amyloidosis: A condition where abnormal proteins build up in the heart muscle [14].

Your care team will use the results of all these tests together to ensure your treatment plan is targeting the right issue [1].

Common questions in this guide

What tests are used to diagnose autoimmune myocarditis?
Doctors usually combine blood tests such as troponin and BNP or NT-proBNP with an ECG and echocardiogram. Cardiac MRI adds information about swelling and tissue injury, and the results are interpreted together because no single test confirms the diagnosis.
What can a cardiac MRI show when myocarditis is suspected?
The 2018 Lake Louise framework looks for signs of heart-muscle swelling on T2-based images and tissue injury on T1-based images, including late gadolinium enhancement. These findings support a diagnosis when combined with other clinical information. Late gadolinium enhancement shows injury or inflammation and does not automatically mean permanent scar.
Can myocarditis affect the heart even when my ejection fraction is normal?
Yes. Global Longitudinal Strain, or GLS, can detect subtle changes in how heart muscle fibers stretch and contract even when the ejection fraction appears normal on a standard echocardiogram.
When is a heart biopsy needed for suspected myocarditis?
An endomyocardial biopsy is considered when its result is likely to change urgent treatment, such as when the heart is failing rapidly or giant-cell or eosinophilic myocarditis is suspected. Because the procedure has risks and inflammation can be patchy, a biopsy can be falsely negative and is not required in every case.
How do doctors distinguish autoimmune myocarditis from a heart attack or Takotsubo syndrome?
Doctors combine the clinical picture with coronary evaluation, blood tests, ECG, echocardiography, and cardiac MRI. This helps distinguish myocarditis from conditions such as MINOCA, Takotsubo syndrome, cardiac amyloidosis, and other causes of heart injury.
What does a high troponin level mean in suspected autoimmune myocarditis?
A high troponin level shows that heart muscle cells are injured or under stress, but it does not identify the cause. Troponin can fluctuate or remain high in autoimmune myocarditis, so doctors interpret it alongside imaging, electrical tests, and other findings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do my Cardiac MRI results meet both the T1 and T2 criteria of the 2018 Lake Louise framework?
  2. 2.Since my coronary arteries were clear, how do we distinguish my condition from other 'look-alikes' like Takotsubo syndrome or MINOCA?
  3. 3.What specific findings on my echocardiogram, such as Global Longitudinal Strain (GLS), suggest my heart is struggling despite a 'normal' ejection fraction?
  4. 4.Is my condition severe or unusual enough to require a heart biopsy to check for specific types like 'giant-cell' or 'eosinophilic' myocarditis?
  5. 5.If we perform a biopsy, will the sample be tested with immunohistochemistry (IHC) to increase the chances of a clear diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Diagnostic and prognostic parameters for immune checkpoint inhibitor-related myocarditis: A meta-analysis.

    Lerchner T, Buehning F, Vogel J, et al.

    European journal of cancer (Oxford, England : 1990) 2026; (239()):116693 doi:10.1016/j.ejca.2026.116693.

    PMID: 41905244
  2. 2

    Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.

    Cau R, Solinas C, De Silva P, et al.

    International journal of cancer 2022; (151(11)):1860-1873 doi:10.1002/ijc.34169.

    PMID: 35730658
  3. 3

    What to do when you question cardiac troponin values.

    Mair J, Lindahl B, Müller C, et al.

    European heart journal. Acute cardiovascular care 2018; (7(6)):577-586 doi:10.1177/2048872617708973.

    PMID: 28485179
  4. 4

    Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study.

    Lim J, Walter HAW, de Bruin-Bon RACM, et al.

    Journal of neuromuscular diseases 2023; (10(2)):185-197 doi:10.3233/JND-221582.

    PMID: 36683515
  5. 5

    Myopericarditis in children and adolescent: is the elevated troponin and chest pain as alarming as we thought?

    Başar EZ, Borakay D, Akalın F

    Cardiology in the young 2022; (32(3)):420-424 doi:10.1017/S1047951121002304.

    PMID: 34165066
  6. 6

    Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist in a patient with new-onset Graves' disease and myocarditis after SARS-CoV2 vaccination.

    Vandebosch C, Dupont M, Verhaert D, Mullens W

    Acta cardiologica 2023; (78(8)):889-893 doi:10.1080/00015385.2022.2135224.

    PMID: 36597848
  7. 7

    Diagnostic utility of the revised Lake Louise criteria in myocarditis associated with active autoimmune rheumatic disease.

    Hua A, Domenech-Ximenos B, Lopez B, et al.

    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2025; (27(2)):101916 doi:10.1016/j.jocmr.2025.101916.

    PMID: 40467038
  8. 8

    Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study).

    Aquaro GD, Ianni U, Licordari R, et al.

    International journal of cardiology 2026; (444()):134016 doi:10.1016/j.ijcard.2025.134016.

    PMID: 41205829
  9. 9

    Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.

    Thavendiranathan P, Zhang L, Zafar A, et al.

    Journal of the American College of Cardiology 2021; (77(12)):1503-1516 doi:10.1016/j.jacc.2021.01.050.

    PMID: 33766256
  10. 10

    Cardiac Magnetic Resonance Imaging in Immune Check-Point Inhibitor Myocarditis: A Systematic Review.

    Arcari L, Tini G, Camastra G, et al.

    Journal of imaging 2022; (8(4)) doi:10.3390/jimaging8040099.

    PMID: 35448226
  11. 11

    A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.

    Guo CW, Alexander M, Dib Y, et al.

    European journal of cancer (Oxford, England : 1990) 2020; (124()):15-24 doi:10.1016/j.ejca.2019.09.009.

    PMID: 31707280
  12. 12

    Refractory ventricular arrhythmia in a patient with suspected immune checkpoint inhibitor-related myocarditis: a case report.

    Jin X, Zheng R

    European heart journal. Case reports 2025; (9(11)):ytaf540 doi:10.1093/ehjcr/ytaf540.

    PMID: 41230355
  13. 13

    Noninvasive Contrast-Enhanced Ultrasound Molecular Imaging Detects Myocardial Inflammatory Response in Autoimmune Myocarditis.

    Steinl DC, Xu L, Khanicheh E, et al.

    Circulation. Cardiovascular imaging 2016; (9(8)).

    PMID: 27502060
  14. 14

    Premature diagnostic closure after pericarditis treatment delays recognition of ATTR cardiomyopathy: a multimodality case report.

    Kocx CJ, Rolfe Z, Lattimore JD, Hunyor I

    European heart journal. Case reports 2026; (10(5)):ytag310 doi:10.1093/ehjcr/ytag310.

    PMID: 42170544
  15. 15

    Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art.

    Campodonico J, Lauri C, Pezzuto B, et al.

    Journal of clinical medicine 2025; (14(21)) doi:10.3390/jcm14217661.

    PMID: 41227056
  16. 16

    Fulminant myocarditis proven by early biopsy and outcomes.

    Huang F, Ammirati E, Ponnaiah M, et al.

    European heart journal 2023; (44(48)):5110-5124 doi:10.1093/eurheartj/ehad707.

    PMID: 37941449
  17. 17

    The State of the Heart Biopsy: A Clinical Review.

    Kiamanesh O, Toma M

    CJC open 2021; (3(4)):524-531 doi:10.1016/j.cjco.2020.11.017.

    PMID: 34027357
  18. 18

    Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis.

    Uccello G, Bonacchi G, Rossi VA, et al.

    Journal of clinical medicine 2023; (13(1)) doi:10.3390/jcm13010150.

    PMID: 38202158
  19. 19

    [Endomyocardial biopsy should be performed in selected patients with suspected myocarditis].

    Ammirati E, Cipriani M, Bonacina E, et al.

    Giornale italiano di cardiologia (2006) 2015; (16(10)):539-43 doi:10.1714/2028.22034.

    PMID: 26444211
  20. 20

    Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome.

    Geisler BP, Raad RA, Esaian D, et al.

    Journal for immunotherapy of cancer 2015; (3()):4 doi:10.1186/s40425-015-0048-2.

    PMID: 25705383
  21. 21

    Reverse takotsubo syndrome heralding as ventricular fibrillation: a case report.

    Basnet A, Sharma NR, Lamichhane S, et al.

    Annals of medicine and surgery (2012) 2023; (85(7)):3744-3747 doi:10.1097/MS9.0000000000000965.

    PMID: 37427166

This page explains testing for suspected autoimmune myocarditis for informational purposes only and does not constitute medical advice. Your cardiology team should interpret your results and decide whether further testing is needed.

Get notified when new evidence is published on Autoimmune myocarditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.